Alan Brash (pharmacologist)

Brash was educated at Strathallan School near Perth, Scotland and Downing College, Cambridge, where he was elected a scholar.^[2] He graduated with a BA in medical sciences in 1970 and proceeded to the University of Edinburgh to study for his PhD, graduating in 1976.^[3] Brash was then appointed a research fellow in the Department of Clinical Pharmacology at the Royal Postgraduate Medical School in London.^[3] Thereafter, he moved to Vanderbilt University.^[3]

During his time at Vanderbilt, Brash's research has focused on the analysis of the mechanisms of formation and transformation of lipoxygenase products with an interest in their physiological role.^[3] His findings have initiated further research on stereochemical aspects of lipoxygenase catalysis and on the role of epithelial lipoxygenases.^[3]

Furthermore, his research has led to more work on the biochemistry of the CYP74 family of cytochrome P450s, and on the catalase-related hemoproteins which also metabolize fatty acid hydroperoxides.^[3] As of 2023^[update], he had published more than 250 research papers.^[4]

In October 2013 he was elected a Fellow of the American Association for the Advancement of Science.^[5]

Official website

This biographical article about a Scottish scientist is a stub. You can help Wikipedia by expanding it.

• v
• t
• e